XML 95 R85.htm IDEA: XBRL DOCUMENT v3.25.1
Derivatives and Hedge Accounting Activities (Schedule of Derivatives not Designated as Hedging Instruments) (Detail) - Derivatives Not Designated as Hedging Instruments - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] $ (70) $ (174)
Virginia Electric and Power Company    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] (46) (105)
Commodity | Operating Revenue    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] (39) 76
Commodity | Operating Revenue | Virginia Electric and Power Company    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] (10) 41
Commodity | Electric Fuel and Other Energy-Related Purchases    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] (34) (148)
Commodity | Electric Fuel and Other Energy-Related Purchases | Virginia Electric and Power Company    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] (36) (146)
Commodity | Discontinued operations    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] 0 (24)
Interest Rate Contract | Interest And Related Charges    
Derivative Instruments Gain Loss [Line Items]    
Amount of Gain (Loss) Recognized in Income on Derivatives [1],[2] $ 3 $ (78)
[1] Excludes amounts related to foreign currency exchange rate derivatives that are deferred to plant under construction within property, plant and equipment and regulatory assets/liabilities that will begin to amortize once the CVOW Commercial Project is placed in service.
[2] Includes derivative activity amortized out of regulatory assets/liabilities. Amounts deferred into regulatory assets/liabilities have no associated effect in the Companies’ Consolidated Statements of Income.